232 related articles for article (PubMed ID: 37046314)
1. Adverse birth outcomes and early-life infections after in utero exposure to corticosteroids for inflammatory bowel disease: a Danish nationwide cohort study.
Jølving LR; Nielsen J; Andersen ML; Friedman S; Nørgård BM
BMC Med; 2023 Apr; 21(1):140. PubMed ID: 37046314
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes.
Boyd HA; Basit S; Harpsøe MC; Wohlfahrt J; Jess T
PLoS One; 2015; 10(6):e0129567. PubMed ID: 26083614
[TBL] [Abstract][Full Text] [Related]
3. Neonatal outcomes in women with Multiple Sclerosis - Influence of disease activity: A Danish nationwide cohort study.
Andersen ML; Jølving LR; Iachina M; Anru PL; Stenager E; Knudsen T; Nørgård BM
Mult Scler Relat Disord; 2024 May; 85():105549. PubMed ID: 38518505
[TBL] [Abstract][Full Text] [Related]
4. Use of azathioprine and corticosteroids during pregnancy and birth outcome in women diagnosed with inflammatory bowel disease.
Plauborg AV; Hansen AV; Garne E
Birth Defects Res A Clin Mol Teratol; 2016 Jun; 106(6):494-9. PubMed ID: 27301563
[TBL] [Abstract][Full Text] [Related]
5. Exposure to corticosteroids in pregnancy is associated with adverse perinatal outcomes among infants of mothers with inflammatory bowel disease: results from the PIANO registry.
Odufalu FD; Long M; Lin K; Mahadevan U;
Gut; 2022 Sep; 71(9):1766-1772. PubMed ID: 34686575
[TBL] [Abstract][Full Text] [Related]
6. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Pregnancies for Women Undergoing Endoscopy While They Were Pregnant: A Nationwide Cohort Study.
Ludvigsson JF; Lebwohl B; Ekbom A; Kiran RP; Green PH; Höijer J; Stephansson O
Gastroenterology; 2017 Feb; 152(3):554-563.e9. PubMed ID: 27773807
[TBL] [Abstract][Full Text] [Related]
8. Reassuring results on birth outcomes in children fathered by men treated with azathioprine/6-mercaptopurine within 3 months before conception: a nationwide cohort study.
Nørgård BM; Magnussen B; Larsen MD; Friedman S
Gut; 2017 Oct; 66(10):1761-1766. PubMed ID: 27456154
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease.
Kammerlander H; Nielsen J; Kjeldsen J; Knudsen T; Friedman S; Nørgård B
Inflamm Bowel Dis; 2017 Jun; 23(6):1011-1018. PubMed ID: 28346274
[TBL] [Abstract][Full Text] [Related]
10. Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study.
Graner S; Svensson T; Beau AB; Damase-Michel C; Engeland A; Furu K; Hviid A; Håberg SE; Mølgaard-Nielsen D; Pasternak B; Kieler H
BMJ; 2017 Feb; 356():j629. PubMed ID: 28246106
[No Abstract] [Full Text] [Related]
11. Pregnancy and birth outcomes in a Danish nationwide cohort of women with autoimmune hepatitis and matched population controls.
Grønbaek L; Vilstrup H; Jepsen P
Aliment Pharmacol Ther; 2018 Sep; 48(6):655-663. PubMed ID: 30058153
[TBL] [Abstract][Full Text] [Related]
12. Safety of topical corticosteroids in pregnancy.
Chi CC; Wang SH; Wojnarowska F; Kirtschig G; Davies E; Bennett C
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD007346. PubMed ID: 26497573
[TBL] [Abstract][Full Text] [Related]
13. Preterm birth in women with inflammatory bowel disease - the association with disease activity and drug treatment.
Bröms G; Granath F; Stephansson O; Kieler H
Scand J Gastroenterol; 2016 Dec; 51(12):1462-1469. PubMed ID: 27739352
[TBL] [Abstract][Full Text] [Related]
14. The risk of chronic diseases and congenital malformations during childhood and adolescence after in utero exposure to thiopurines.
Jølving LR; Anru PL; Nielsen J; Friedman S; Nørgård BM
Aliment Pharmacol Ther; 2021 Oct; 54(8):1061-1069. PubMed ID: 34464467
[TBL] [Abstract][Full Text] [Related]
15. Effects of repeat prenatal corticosteroids given to women at risk of preterm birth: An individual participant data meta-analysis.
Crowther CA; Middleton PF; Voysey M; Askie L; Zhang S; Martlow TK; Aghajafari F; Asztalos EV; Brocklehurst P; Dutta S; Garite TJ; Guinn DA; Hallman M; Hardy P; Lee MJ; Maurel K; Mazumder P; McEvoy C; Murphy KE; Peltoniemi OM; Thom EA; Wapner RJ; Doyle LW;
PLoS Med; 2019 Apr; 16(4):e1002771. PubMed ID: 30978205
[TBL] [Abstract][Full Text] [Related]
16. Intrapartum corticosteroid use significantly increases the risk of gestational diabetes in women with inflammatory bowel disease.
Leung YP; Kaplan GG; Coward S; Tanyingoh D; Kaplan BJ; Johnston DW; Barkema HW; Ghosh S; Panaccione R; Seow CH; ;
J Crohns Colitis; 2015 Mar; 9(3):223-30. PubMed ID: 25576754
[TBL] [Abstract][Full Text] [Related]
17. Birth Outcomes in Children Fathered by Men Treated with Anti-TNF-α Agents Before Conception.
Larsen MD; Friedman S; Magnussen B; Nørgård BM
Am J Gastroenterol; 2016 Nov; 111(11):1608-1613. PubMed ID: 27619836
[TBL] [Abstract][Full Text] [Related]
18. Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications.
Ban L; Tata LJ; Fiaschi L; Card T
Gastroenterology; 2014 Jan; 146(1):76-84. PubMed ID: 24126096
[TBL] [Abstract][Full Text] [Related]
19. Anti-TNF-α Use During the Third Trimester of Pregnancy in Women with Moderate-severe Inflammatory Bowel Disease and the Risk of Preterm Birth and Low Birth Weight.
Kammerlander H; Nielsen J; Knudsen T; Kjeldsen J; Friedman S; Nørgård BM
Inflamm Bowel Dis; 2017 Nov; 23(11):1916-1923. PubMed ID: 28858070
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study.
Chaparro M; Verreth A; Lobaton T; Gravito-Soares E; Julsgaard M; Savarino E; Magro F; Biron AI; Lopez-Serrano P; Casanova MJ; Gompertz M; Vitor S; Arroyo M; Pugliese D; Zabana Y; Vicente R; Aguas M; Shitrit BA; Gutierrez A; Doherty GA; Fernandez-Salazar L; Cadilla MJ; Huguet JM; OʼToole A; Stasi E; Marcos MN; Villoria A; Karmiris K; Rahier JF; Rodriguez C; Palomares DM; Fiorino G; Benitez JM; Principi M; Naftali T; Taxonera C; Mantzaris G; Sebkova L; Iade B; Lissner D; Bradley FI; Roman LA; Marin-Jimenez I; Merino O; Sierra M; Van Domselaar M; Caprioli F; Guerra I; Peixe P; Piqueras M; Rodriguez-Lago I; Ber Y; van Hoeve K; Torres P; Gravito-Soares M; Rudbeck-Resdal D; Bartolo O; Peixoto A; Martin G; Armuzzi A; Garre A; Donday MG; de Carpi MFJ; Gisbert JP
Am J Gastroenterol; 2018 Mar; 113(3):396-403. PubMed ID: 29460920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]